Family Care Hospitals Notifies BSE of Director Re-appointments for Second Terms

3 min read     Updated on 21 Feb 2026, 08:11 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Family Care Hospitals Limited formally informed BSE Limited about the successful re-appointment of three key directors for their second terms following postal ballot approval on February 20, 2026. The appointments include Mrs. Archana Chirawawala and Mr. Sanjeev Seth as Independent Directors, and Mr. Suchit Raghunath Modshing as Whole Time Director, all effective February 28, 2026.

powered bylight_fuzz_icon
33218114

*this image is generated using AI for illustrative purposes only.

Family Care Hospitals Limited has formally notified BSE Limited about the successful re-appointment of three key directors for their second terms, following the completion of postal ballot process on February 20, 2026. The company submitted the intimation on February 21, 2026, under Regulation 30 of SEBI (LODR) Regulations, 2015, confirming that all three re-appointments will be effective from February 28, 2026.

Postal Ballot Results Overview

The postal ballot covered three special resolutions, all of which received strong shareholder support with 96.52% approval rate across all resolutions. A total of 85 members participated in the e-voting process, with over 10.78 million valid votes cast across the resolutions.

Resolution Details: Type Outcome Approval Rate
Re-appointment of Mr. Suchit Raghunath Modshing as Whole Time Director (5-year term) Special Resolution Passed 96.52%
Re-appointment of Mrs. Archana Chirawawala as Independent Director (Second term) Special Resolution Passed 96.52%
Re-appointment of Mr. Sanjeev Seth as Independent Director (Second term) Special Resolution Passed 96.52%

Director Profiles and Appointment Terms

Mrs. Archana Chirawawala (DIN: 09721625) has been re-appointed as Non-Executive Independent Director for a second term of five consecutive years. She is a Chartered Accountant by profession and proprietor of Chirawawala & Associates, bringing over 20 years of experience in accounting, book keeping, income tax, GST, and capital market advisory services.

Mr. Sanjeev Seth (DIN: 10974972) secured his second term as Non-Executive Independent Director for five years. He brings 33 years of industry experience, including 16 years in sales across multiple therapies in Indian and global pharma, and 17 years in marketing across global and Indian organizations.

Mr. Suchit Raghunath Modshing (DIN: 10974977) has been re-appointed as Executive Whole Time Director for a further period of five years. He is an experienced administrative assistant with over 12 years of industry expertise, holding a Bachelor of Commerce degree and specializing in Microsoft Office applications with data management certification.

Director Appointment Details:

Director: Position Term Duration Effective Date Experience
Mrs. Archana Chirawawala Non-Executive Independent Director 5 years (Second term) February 28, 2026 20+ years (CA, Advisory)
Mr. Sanjeev Seth Non-Executive Independent Director 5 years (Second term) February 28, 2026 33 years (Pharma, Marketing)
Mr. Suchit Raghunath Modshing Executive Whole Time Director 5 years February 28, 2026 12+ years (Administration)

Detailed Voting Results and Participation

The company had sent email notifications to 43,562 members who had registered their email addresses, with the record date set as January 16, 2026. The total number of shareholders on record date was 47,300. The voting process was conducted entirely through remote e-voting, with no physical postal ballot forms distributed in compliance with MCA circulars.

Resolution-wise Voting Breakdown:

Resolution: Valid Votes Votes in Favor Votes Against Members Participated
Resolution 1 (Suchit Modshing) 10788307 10412828 375479 85
Resolution 2 (Archana Chirawawala) 10788303 10412811 375492 85
Resolution 3 (Sanjeev Seth) 10788303 10412824 375479 85

Regulatory Compliance and Scrutinizer Report

Mr. Mukesh Siroya, Proprietor of M. Siroya & Co., Practicing Company Secretaries, served as the appointed Scrutinizer for the postal ballot process. The scrutinizer was appointed by the Board of Directors on January 20, 2026, and submitted the final report on February 21, 2026, pursuant to Section 108 of the Companies Act, 2013.

The remote e-voting facility was provided by Purva Sharegistry (India) Private Limited, ensuring a fair and transparent voting process. The voting period concluded at 5:00 PM on February 20, 2026, with all resolutions achieving the requisite majority for passage. The company confirmed that none of the re-appointed directors are debarred from holding office by virtue of any SEBI order or other authority.

Historical Stock Returns for Family Care Hospitals

1 Day5 Days1 Month6 Months1 Year5 Years
-3.70%-10.96%-22.62%-48.82%-34.01%-81.60%
like16
dislike

Dealmoney Commodities Revises Disclosure for ₹180 Crore Warrant Acquisition in Family Care Hospitals

1 min read     Updated on 21 Jan 2026, 01:44 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Dealmoney Commodities Private Limited has submitted a revised disclosure correcting the diluted share capital figure in its warrant acquisition of Family Care Hospitals Limited. The company acquired 1.80 crore warrants for ₹180 crores through preferential allotment, representing a 24.76% stake. The corrected disclosure shows Family Care Hospitals' diluted share capital at 72.69 crore equity shares.

powered bylight_fuzz_icon
30528889

*this image is generated using AI for illustrative purposes only.

Dealmoney Commodities Private Limited has filed a revised regulatory disclosure to correct an inadvertent error in previously submitted documentation regarding its warrant acquisition in Family Care Hospitals Limited. The correction pertains to the diluted paid-up share capital figure disclosed under SEBI's substantial acquisition regulations.

Transaction Details

The warrant acquisition transaction involves significant financial parameters that demonstrate Dealmoney's strategic investment in the healthcare sector:

Parameter Details
Warrants Acquired 1,80,00,000
Acquisition Value ₹180.00 crores
Stake Percentage 24.76%
Acquisition Mode Preferential allotment
Transaction Date December 26, 2025

Share Capital Structure

The revised disclosure clarifies Family Care Hospitals' capital structure following the warrant allotment:

Capital Type Number of Shares Face Value
Current Equity Share Capital 54,01,47,774 ₹10.00 each
Total Diluted Share Capital 72,69,22,774 ₹10.00 each
Warrants Outstanding 1,80,00,000 ₹10.00 each

Regulatory Compliance

The original disclosure was submitted on December 29, 2025, under Regulation 29(1) of SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011. Dealmoney identified the error in the diluted share capital figure and promptly filed the corrected version on January 21, 2026. The company belongs to the promoter group of Family Care Hospitals Limited, which is listed on BSE Limited under scrip code 516110.

Shareholding Position

Prior to this acquisition, Dealmoney held no shares, voting rights, or convertible instruments in Family Care Hospitals. The warrant acquisition represents the company's first substantial investment in the target company. Post-acquisition, Dealmoney's total holding stands at 1.80 crore warrants, representing 24.76% of both the total share capital and diluted voting capital.

Corporate Information

Dealmoney Commodities Private Limited operates from its registered office in Thane, Maharashtra. The revised disclosure was signed by Director Anil R Bapardekar (DIN: 10126442), emphasizing the company's commitment to accurate regulatory reporting and transparency in substantial acquisition transactions.

Historical Stock Returns for Family Care Hospitals

1 Day5 Days1 Month6 Months1 Year5 Years
-3.70%-10.96%-22.62%-48.82%-34.01%-81.60%
like16
dislike

More News on Family Care Hospitals

1 Year Returns:-34.01%